10 May 2016 --- OmniActive Health Technologies has been granted a European patent for Lutemax 2020 (Patent No: EP2473065B1) entitled “A Xanthophyll Composition Containing Macular Pigments and a Process for its Preparation.”
The patent covers the composition and process of preparation for Lutemax 2020, “a xanthophyll composition containing macular pigments consisting of trans-lutein, zeaxanthin isomers – namely (R,R-zeaxanthin) and (R,S-zeaxanthin) – derived from the plant extract/oleoresin containing xanthophylls/xanthophyll esters which is safe for human consumption and useful for nutrition and health care...”
Lutein and zeaxanthin are not produced by the body and their specialized locations and functions emphasize the need to consume all three macular carotenoids through diet or supplementation. Lutein and R,R-zeaxanthin are found in dark green leafy vegetables and yellow to orange fruits and vegetables, while R,S-zeaxanthin is found in fish such as salmon, sardine and trout.
“Lutemax 2020 is an innovative, science-backed ingredient providing all three macular carotenoids – lutein, RR-zeaxanthin and RS-zeaxanthin – at a 5:1 ratio of lutein:zeaxanthin isomers to optimally support eye health,” said Lynda Doyle, VP of Global Marketing, OmniActive Health Technologies.
“This European patent further supports the importance and safety of all three macular carotenoids, as well as OmniActive’s commitment to educate industry members, consumers, researchers and healthcare professionals about the important role macular carotenoids play in health – eye, skin and brain – through each stage of life.”
OmniActive Health Technologies offers a range of ingredients, which are innovative and scientifically validated for dietary supplementation, nutritional fortification, functional food/beverage, coloring, flavor enhancement and personal care applications.
The company addresses complex challenges for customers in the dietary supplement, food and beverage space using technology-driven, sustainable solutions with application support within a global regulatory framework – for a new ingredient to add to a finished product, or an ingredient solution to enhance an existing ingredient.
Core products include carotenoids, plant extracts and specialty functional ingredients. OmniActive leverages international R&D strengths to deploy an array of state-of-the-art manufacturing technologies in extraction, purification, isolation and delivery of nutritional actives.
The company's manufacturing operations are located at multiple sites in India and are cGMP and HACCP system compliant.
04 Mar 2024 --- Today, FrieslandCampina Ingredients launches Biotis DHA FlexP 15 and Biotis DHA FlexP 20, two new algae-based, microencapsulated DHA (docosahexaenoic...Read More
22 Feb 2024 --- Findings from a supplementation study with Lutemax Kids, a proprietary, low-dose extract of lutein and zeaxanthin isomers developed by OmniActive Health...Read More
08 Feb 2024 --- The quest to maintain optimal eye health is spurring interest in understanding the role of supplements, nutraceuticals and innovative ingredients to...Read More
02 Feb 2024 --- This week in nutrition news, the merger of Novozyme and Chr. Hansen into the newly minted Novonesis was completed, while legacy Novozymes revealed marked...Read More
01 Feb 2024 --- As people’s screen time increases and age-related eye concerns rise, the demand for offerings that help maintain eye health continues to expand....Read More